Clinical Trials Sponsored by Biosense Webster EMEA

Total 126 results

Biosense Webster EMEA

Completed

FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)

Atrial Fibrillation

Italy
Biosense Webster EMEA

Terminated

CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation (CACAF-2)

Atrial Fibrillation

Italy, United Kingdom, Finland
Biosense Webster EMEA

Completed

European Carto® XP REgistry for Validating Specialized CFAE SOftware (EXPRESSO)

Atrial Fibrillation

France, Germany, Hungary
Biosense Webster, Inc.

Recruiting

A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAFOUS (PulseSmart)

Atrial Fibrillation

Australia, Canada
Biosense Webster, Inc.

Recruiting

A Study For Treatment of Paroxysmal Atrial Fibrillation (PAF) With the OMNYPULSE Catheter and the TRUPULSE Generator (Omny-IRE)

Atrial Fibrillation

Belgium, Canada, Netherlands, Lithuania, Croatia, Germany, Italy, Czechia
Biosense Webster, Inc.

Active, not recruiting

A Study of Multi-electrode Circular Irreversible Electroporation (IRE) Catheter and Multi-Channel IRE Generator in Paroxysmal Atrial Fibrillation (AF) (AFIRE)

Refractory Paroxysmal Atrial Fibrillation

China
Biosense Webster, Inc.

Completed

Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation (Q-FFICIENCY)

Paroxysmal Atrial Fibrillation

United States
Biosense Webster, Inc.

Completed

Multi-electrode Radiofrequency Balloon Catheter Use for the Isolation of the Pulmonary Veins. (SHINE)

Paroxysmal Atrial Fibrillation

United Kingdom, Italy, Czechia
Biosense Webster, Inc.

Terminated

Atrial Fibrillation Progression Trial (ATTEST)

Atrial Fibrillation

Korea, Republic of, Germany, Belgium, Norway, Austria, Ireland, United Kingdom, Australia, Spain, Sweden, Latvia, Hungary, Italy, Poland, Russian Federation
Biosense Webster, Inc.

Completed

Repetitive Activation Patterns and Focal Impulses Identification and Ablation in Persistent AF (RAPID-AF)

Persistent Atrial Fibrillation

United Kingdom, Belgium, Czechia, Canada
Biosense Webster, Inc.

Completed

Evaluation of a Multi-electrode Linear Type Catheter (D-1368-01-SI)

Persistent Atrial Fibrillation

United Kingdom, Italy
Biosense Webster, Inc.

Terminated

nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

Atrial Fibrillation

United States, United Kingdom, Italy, Czechia, Belgium, Hungary
Biosense Webster, Inc.

Completed

SMART China, A Multi-center Clinical Registry Study

Atrial Fibrillation

China
Biosense Webster, Inc.

Completed

THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS

Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation

United States
Biosense Webster, Inc.

Completed

FIND CAN Trial: "CF-172" (FIND CAN)

Persistent Atrial Fibrillation

Canada
Biosense Webster, Inc.

Terminated

Guided Radiofrequency Ablation Using the CARTO® 3 and NavX™ Systems for the Treatment of Paroxysmal Atrial Fibrillation (CO1)

Paroxysmal Atrial Fibrillation

Canada
Biosense Webster, Inc.

Withdrawn

CARTO 3 Human Patch Study (Human Patch)

Healthy
Biosense Webster, Inc.

Completed

Study of a New Catheter Using Force Sensing Capabilities for the Treatment of Atrial Fibrillation and Ventricular Tachycardia (EZCF-125)

Atrial Fibrillation | Ischemic Ventricular Tachycardia

Czech Republic
Biosense Webster, Inc.

Terminated

Efficacy, Safety and Efficiency Study of CARTO® 3 System Guided THERMOCOOL® Catheter Ablation Versus Fluoroscopy Guided Ablation With the Pulmonary Vein Ablation Catheter® (PVAC®) (CLARITY-AF)

Atrial Fibrillation

Netherlands, Belgium, Canada, Denmark, Germany, United Kingdom
Biosense Webster, Inc.

Completed

THERMOCOOL® SMARTTOUCH™ Registry

Symptomatic Atrial Fibrillation

Belgium, Germany, United Kingdom, Canada, Australia, France, Italy, Monaco
Biosense Webster, Inc.

Completed

Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System (AdmIRE)

Atrial Fibrillation

United States
Biosense Webster, Inc.

Completed

A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter

Ventricular Tachycardia | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Scar-related Atrial Tachycardia | Premature Ventricular Complex

Croatia, Italy, Israel
Biosense Webster, Inc.

Completed

A Study Assessing Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter (COSMOS)

Ventricular Tachycardia | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Scar-related Atrial Tachycardia | Premature Ventricular Complex

Croatia, Belgium, Italy
Biosense Webster, Inc.

Completed

Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU)

Paroxysmal Atrial Fibrillation

United States
Biosense Webster, Inc.

Completed

A Study for Treatment of Paroxysmal Atrial Fibrillation (PAF) by Pulsed Field Ablation (PFA) System With Irreversible Electroporation (IRE) (inspIRE)

Atrial Fibrillation

Canada, Belgium, Austria, Croatia, Czechia, France, Italy, Lithuania
Biosense Webster, Inc.

Completed

Performance of QDOT Micro™ Catheter With nGEN Generator for Patients With AFIB.

Atrial Fibrillation

Canada
Biosense Webster, Inc.

Completed

Safety and Effectiveness of STSF Catheter Evaluated for Treating Symptomatic Persistent Atrial Fibrillation (PsAF) (PRECEPT)

Atrial Fibrillation

United States, Canada
Biosense Webster, Inc.

Terminated

Oral Anticoagulation Therapy Pilot Study (OAT)

Paroxysmal Atrial Fibrillation

United States, Germany, Italy, France
Biosense Webster, Inc.

Completed

Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal Atrial Fibrillation. (QDOT-FAST)

Paroxysmal Atrial Fibrillation

Belgium, Czechia, Austria, Italy
Biosense Webster, Inc.

Completed

Evaluation of Ablation Index and VISITAG™ (ABI-173) (VISTAX)

Paroxysmal Atrial Fibrillation

Denmark, Netherlands, United Kingdom, France, Belgium, Austria, Ireland, Italy, Switzerland
Biosense Webster, Inc.

Completed

NAVISTAR® THERMOCOOL® Catheter Post Approval Registry (AF Registry)

Paroxysmal Atrial Fibrillation

United States, Canada
Biosense Webster, Inc.

Completed

Identification for the Treatment of Complex Arrhythmias

Arrhythmias

Belgium, Czechia
Biosense Webster, Inc.

Completed

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation (Afib IDE)

Heart Diseases | Atrial Fibrillation | Arrhythmia

United States, Italy, Brazil, Canada, Czechia
Biosense Webster, Inc.

Terminated

Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators (ASPIRE)

Ventricular Tachycardia | Ischemic

United States
Biosense Webster, Inc.

Completed

REVOLUTION (WFCC-133) - Treatment of Paroxysmal Atrial Fibrillation (REVOLUTION)

Paroxysmal Atrial Fibrillation

Czechia, Belgium, Denmark, France, Germany, Italy
Biosense Webster, Inc.

Completed

Picasso NAV High-Density Mapping Catheter for Signal Analysis of Complex Arrhythmias - First-In-Man

Arrhythmias

Czech Republic, Belgium
Biosense Webster, Inc.

Completed

NAVISTAR® THERMOCOOL® SF Catheter: Observational Study (SFAF)

Atrial Fibrillation | Paroxysmal Arrhythmia

United States
Biosense Webster, Inc.

Completed

CARTO® 3 System and Real Time Intracardiac Ultrasound (IUAF)

Atrial Fibrillation | Paroxysmal AF

United States
Biosense Webster, Inc.

Terminated

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study (AFTX)

Heart Diseases | Atrial Fibrillation | Arrhythmia

United States
Biosense Webster, Inc.

Completed

Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter

Atrial Flutter

United States
Biosense Webster, Inc.

Recruiting

A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAF (SMARTPULSE PAF)

Drug Refractory Paroxysmal Atrial Fibrillation

United States
Biosense Webster, Inc.

Recruiting

An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac Arrhythmias

Cardiac Arrhythmias

United Kingdom, Belgium, Israel, France, Austria, Germany, Italy, Ireland
Biosense Webster, Inc.

Active, not recruiting

A Study For Treatment Of Paroxysmal Atrial Fibrillation (PAF) With The THERMOCOOL SMARTTOUCH SF Catheter and TRUPULSE Generator (SmartfIRE)

Atrial Fibrillation

Belgium, Denmark, Austria, Lithuania
Biosense Webster, Inc.

Active, not recruiting

THERMOCOOL SMARTTOUCH®SF Catheters With Ablation Index Study (STSF)

Paroxysmal Atrial Fibrillation

China
Biosense Webster, Inc.

Completed

A Study Assessing Arrhythmia Mapping With the Multi-Electrode OPTRELL™ Mapping Catheter (OPTIMUM)

Tachycardia, Ventricular | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Ventricular Premature Complexes | Scar-related Atrial Tachycardia

Belgium, Lithuania
Biosense Webster, Inc.

Completed

Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (STELLAR)

Atrial Fibrillation

United States, China, Italy
Biosense Webster, Inc.

Completed

Clinical Study for Workflow and Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System for Treating Symptomatic Paroxysmal AF (QDOT-Micro)

Atrial Fibrillation

Belgium, Czechia, Denmark, Italy
Biosense Webster, Inc.

Completed

SMART-SF Radiofrequency Ablation Safety Study

Atrial Fibrillation

United States
Biosense Webster, Inc.

Completed

RENABLATE-II Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension - 157 (RENABLATE-II)

Hypertension, Renal

Czech Republic, Italy, New Zealand, Spain
Biosense Webster, Inc.

Completed

RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension

Hypertension, Renal

Belgium, Czech Republic, Italy, Australia, Denmark

Clinical Trials Sponsored by Biosense Webster EMEA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations